Mengran Li

6.4k total citations
26 papers, 203 citations indexed

About

Mengran Li is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Mengran Li has authored 26 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Mengran Li's work include RNA modifications and cancer (4 papers), Cancer-related gene regulation (3 papers) and Mangiferin and Mango Extracts (3 papers). Mengran Li is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related gene regulation (3 papers) and Mangiferin and Mango Extracts (3 papers). Mengran Li collaborates with scholars based in China, Japan and Russia. Mengran Li's co-authors include Hongbin Guo, Zili Zhang, Yingqian Wang, Mei Guo, Feng Zhang, Jiangjuan Shao, Xuefen Xu, Min Shen, Chunxiao Wu and Yujia Li and has published in prestigious journals such as Analytical Chemistry, Bioresource Technology and Free Radical Biology and Medicine.

In The Last Decade

Mengran Li

22 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengran Li China 9 92 45 34 30 29 26 203
Yujiao Sun China 9 109 1.2× 42 0.9× 22 0.6× 25 0.8× 34 1.2× 18 226
Ying Cao China 10 104 1.1× 34 0.8× 41 1.2× 63 2.1× 18 0.6× 30 274
Zhaohu Xie China 7 196 2.1× 64 1.4× 53 1.6× 40 1.3× 21 0.7× 18 332
Zonglin Li China 7 88 1.0× 57 1.3× 53 1.6× 34 1.1× 64 2.2× 36 261
Youhong Dong China 10 95 1.0× 47 1.0× 27 0.8× 30 1.0× 42 1.4× 30 208
Jiahui Liu China 9 111 1.2× 42 0.9× 52 1.5× 29 1.0× 14 0.5× 34 275
Chaorun Dong China 7 150 1.6× 36 0.8× 28 0.8× 30 1.0× 18 0.6× 10 227
Jiaxuan Wang China 8 41 0.4× 19 0.4× 20 0.6× 33 1.1× 16 0.6× 29 161
Wenbin Jiang China 10 116 1.3× 41 0.9× 14 0.4× 75 2.5× 32 1.1× 19 297
Baolin Qian China 10 124 1.3× 39 0.9× 24 0.7× 62 2.1× 41 1.4× 34 290

Countries citing papers authored by Mengran Li

Since Specialization
Citations

This map shows the geographic impact of Mengran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengran Li more than expected).

Fields of papers citing papers by Mengran Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengran Li. The network helps show where Mengran Li may publish in the future.

Co-authorship network of co-authors of Mengran Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengran Li. A scholar is included among the top collaborators of Mengran Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengran Li. Mengran Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mengran, et al.. (2025). Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein. Free Radical Biology and Medicine. 231. 120–135. 5 indexed citations
2.
Wu, Yang, et al.. (2025). The m6A modification in cancer: roles, implications, and its potential in therapy. Molecular Biomedicine. 6(1). 67–67.
3.
Li, Mengran, Yanan Yang, Jun Xuan, Hongping Zhou, & Fei Li. (2025). One-Pot Synthesis of 1,4-(Phosphonyl)[60]fullerenol via a DBU-Promoted, Multicomponent Domino Reaction of H-Phosphonates, C 60 , and HBr/DMSO. The Journal of Organic Chemistry. 90(47). 16762–16770.
4.
Liu, Yuanhong, et al.. (2025). The association of visceral and subcutaneous fat areas with phenotypic age in non-elderly adults, mediated by HOMA-IR and HDL-C. Lipids in Health and Disease. 24(1). 22–22. 2 indexed citations
5.
Li, Mengran, et al.. (2025). New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy. Frontiers in Immunology. 16. 1533940–1533940. 1 indexed citations
6.
Liu, Guangchao, Mengfei Li, Zhe Zhang, et al.. (2025). Enhancement of grape heat tolerance through VvbZIP36-mediated quercetin production. International Journal of Biological Macromolecules. 297. 139826–139826. 3 indexed citations
7.
Bao, Zhengyang, Ming Xu, Yinhui Kan, et al.. (2025). Dihydroartemisinin requires NR1D1 mediated Rab7 ubiquitination to regulate hepatic stellate cells lipophagy in liver fibrosis. International Journal of Biological Macromolecules. 305(Pt 1). 141055–141055. 2 indexed citations
8.
Su, Ning, Wei Liu, Mengran Li, et al.. (2025). An effective cell-penetrating peptide-based loading method to extracellular vesicles and enhancement in cellular delivery of drugs. Analytical and Bioanalytical Chemistry. 417(8). 1449–1459. 3 indexed citations
9.
Wu, Yang, et al.. (2024). Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. World Journal of Gastroenterology. 30(43). 4660–4668. 2 indexed citations
10.
Li, Mengran, et al.. (2024). A Universal Positioning System based on Multi-sensor Fusion for Small Mobile Robots. 187–188. 1 indexed citations
11.
Li, Yujia, Mei Guo, Mengran Li, et al.. (2023). Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma. Redox Biology. 69. 102971–102971. 42 indexed citations
12.
Wei, Ye, Taomei Liu, Yuping Liu, et al.. (2023). Enhancing gliotoxins production in deep-sea derived fungus Dichotomocyes cejpii by engineering the biosynthetic pathway. Bioresource Technology. 377. 128905–128905. 4 indexed citations
13.
Zheng, Haoyang, Ning Su, Guoquan Yan, et al.. (2023). Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers. Analytica Chimica Acta. 1287. 342109–342109. 6 indexed citations
14.
Wu, Yang, Chun Zhang, Mei Guo, et al.. (2022). Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds. Frontiers in Pharmacology. 13. 1042651–1042651. 9 indexed citations
15.
Lei, Chun‐Tao, Mengran Li, Yang Qiu, et al.. (2022). Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1. Cell Death and Disease. 13(2). 184–184. 10 indexed citations
16.
Li, Mengran, Chun‐Tao Lei, Hui Tang, et al.. (2022). MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy. International Journal of Biological Sciences. 18(5). 1896–1911. 18 indexed citations
17.
Li, Mengran, et al.. (2021). Expression and Purification of a PEDV-Neutralizing Antibody and Its Functional Verification. Viruses. 13(3). 472–472. 11 indexed citations
18.
Tamada, Satoshi, Chihiro Kondoh, Nobuaki Matsubara, et al.. (2021). Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study. International Journal of Clinical Oncology. 27(1). 154–164. 20 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujiao Sun Breakdown of academic impact, for papers by Ying Cao Breakdown of academic impact, for papers by Zhaohu Xie Breakdown of academic impact, for papers by Zonglin Li Breakdown of academic impact, for papers by Youhong Dong Breakdown of academic impact, for papers by Jiahui Liu Breakdown of academic impact, for papers by Chaorun Dong Breakdown of academic impact, for papers by Jiaxuan Wang Breakdown of academic impact, for papers by Wenbin Jiang Breakdown of academic impact, for papers by Baolin Qian
Rankless by CCL
2026